Jakubov Katarina, Petr Vojtech, Zahradka Ivan, Girmanova Eva, Hruba Petra, Keleman Roman, Viklicky Ondrej
Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Transplant Direct. 2024 Nov 14;10(12):e1730. doi: 10.1097/TXD.0000000000001730. eCollection 2024 Dec.
Acute kidney injury in deceased donors (D-AKI) is one of the common causes of donor kidney discard. The risk factors for D-AKI and its impact on kidney transplantation outcomes are not yet fully understood.
This single-center, retrospective cohort study included 388 donors referred between June 2021 and December 2022. D-AKI was defined and staged according to kidney disease: Improving global outcomes criteria, and donor clinical variables were analyzed to identify risk factors for D-AKI. Delayed graft function and estimated glomerular filtration rate (eGFR) at 6 mo were evaluated in 369 kidney grafts transplanted from donors with and without D-AKI.
AKI was present in 171 deceased donors (44.1%), with 117 (30.2%) classified as AKI stage 1 and 54 (14%) as AKI stages 2 or 3. Donor history of hypertension (odds ratio [OR] 1.93; 95% confidence interval [CI], 1.21-3.10; = 0.005), history of diabetes (OR 2.2; 95% CI, 1.21-3.98; = 0.008), and anoxia as the cause of death (OR 2.61; 95% CI, 1.5-4.61; < 0.001) were independently associated with an increased risk of D-AKI. Multivariable mixed models identified donor age (β -0.49; 95% CI, -0.71 to -0.28; < 0.001) as the only independent risk factor for lower eGFR at 6 mo. D-AKI was not associated with delayed graft function or lower eGFR at 6 mo.
Hypertension, diabetes, and anoxia as the cause of death were identified as risk factors for AKI in deceased donors. D-AKI should not be used as the sole criterion to assess the risk of poor graft outcomes. A broader range of donor variables should be considered when evaluating graft viability.
已故供体急性肾损伤(D-AKI)是供肾废弃的常见原因之一。D-AKI的危险因素及其对肾移植结局的影响尚未完全明确。
这项单中心回顾性队列研究纳入了2021年6月至2022年12月期间转诊的388名供体。根据肾脏病:改善全球预后标准对D-AKI进行定义和分期,并分析供体临床变量以确定D-AKI的危险因素。对369例接受有或无D-AKI供体肾脏移植的肾移植受者,评估其移植肾功能延迟恢复情况及6个月时的估计肾小球滤过率(eGFR)。
171例已故供体(44.1%)存在急性肾损伤,其中117例(30.2%)为1期急性肾损伤,54例(14%)为2期或3期急性肾损伤。供体高血压病史(比值比[OR]1.93;95%置信区间[CI],1.21 - 3.10;P = 0.005)、糖尿病病史(OR 2.2;95% CI,1.21 - 3.98;P = 0.008)以及缺氧作为死亡原因(OR 2.61;95% CI,1.5 - 4.61;P < 0.001)与D-AKI风险增加独立相关。多变量混合模型确定供体年龄(β -0.49;95% CI,-0.71至-0.28;P < 0.001)是6个月时eGFR降低的唯一独立危险因素。D-AKI与移植肾功能延迟恢复或6个月时较低的eGFR无关。
高血压、糖尿病以及缺氧作为死亡原因被确定为已故供体急性肾损伤的危险因素。D-AKI不应作为评估移植预后不良风险的唯一标准。在评估移植肾存活能力时,应考虑更广泛的供体变量。